Site‐Directed Chemical Modification of Amyloid by Polyoxometalates for Inhibition of Protein Misfolding and Aggregation

Abstract

AbstractPost‐translational modification (PTM) of protein can significantly change protein conformation and function. Inspired by the natural PTM, we present a new approach to inhibit amyloid aggregation by chemical PTM modification. Polyoxometalates (POMs) were used as examples of inhibitors of β‐amyloid peptide (Aβ) aggregation to illustrate the chemical PTM method. After the POMs were modified with thiazolidinethione (TZ), the resulting POMD‐TZ acted as a chemical PTM agent and could covalently modify Aβ site‐selectively at Lys16. Multiple biophysical techniques and biochemical assays have been employed to show the superiority of the chemical PTM method compared to traditional Aβ inhibitors. Since Aβ oligomers are more cytotoxic, we further functionalized POMD‐TZ with an Aβ‐targeted peptide and a fluorescent probe to obtain an “Aβ oligomer sensitive” probe. The use of PTM agents for the site‐directed chemical modification of proteins provides a new way to regulate amyloid aggregation.